Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer (NCT02296229)
Study of Stereotactic Body Radiotherapy (SBRT) for High-Risk Localized Prostrate Cancer
🩺 Plain-English Summary (8th-Grade Level)
This clinical trial studies stereotactic body radiation therapy in treating patients with high-risk prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Stereotactic body radiation therapy is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may kill more tumor cells and cause less damage to normal tissue. Studying quality of life in patients undergoing stereotactic body radiation therapy may help identify the long-term effects of treatment on patients with prostate cancer.
Who can join: Review the eligibility criteria below.
Location: Jonsson Comprehensive Cancer Center — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Jonsson Comprehensive Cancer Center — Los Angeles, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Adenocarcinoma of the Prostate
- Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer — Los Angeles, California
- Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer — Philadelphia, Pennsylvania
- Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer — Jacksonville, Florida
Explore by condition: All Adenocarcinoma of the Prostate clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.